Terms: = Sarcomas AND CIC, ENSG00000079432, 23152, Q96RK0, KIAA0306 AND Treatment
46 results:
1. Clinical outcomes of patients with cic-rearranged sarcoma: a single institution retrospective analysis.
Murphy J; Resch EE; Leland C; Meyer CF; Llosa NJ; Gross JM; Pratilas CA
J Cancer Res Clin Oncol; 2024 Mar; 150(3):112. PubMed ID: 38436779
[TBL] [Abstract] [Full Text] [Related]
2. A cic-related-epigenetic factors-based model associated with prediction, the tumor microenvironment and drug sensitivity in osteosarcoma.
Yu B; Geng C; Wu Z; Zhang Z; Zhang A; Yang Z; Huang J; Xiong Y; Yang H; Chen Z
Sci Rep; 2024 Jan; 14(1):1308. PubMed ID: 38225273
[TBL] [Abstract] [Full Text] [Related]
3. Clinical model of pulmonary metastasis in patients with osteosarcoma: A new multiple machine learning-based risk prediction.
Su Z; Huang F; Yin C; Yu Y; Yu C
J Orthop Surg (Hong Kong); 2023; 31(2):10225536231177102. PubMed ID: 37288764
[TBL] [Abstract] [Full Text] [Related]
4. [cic-rearranged sarcoma: a case report and literature review].
Sidorov IV; Fedorova AS; Konopleva EI; Makarova NP; Sharlai AS; Konovalov DM
Arkh Patol; 2023; 85(3):64-70. PubMed ID: 37272442
[No Abstract] [Full Text] [Related]
5. Bad to the Bone: Emerging Approaches to Aggressive Bone sarcomas.
Wood GE; Graves LA; Rubin EM; Reed DR; Riedel RF; Strauss SJ
Am Soc Clin Oncol Educ Book; 2023 May; 43():e390306. PubMed ID: 37220319
[TBL] [Abstract] [Full Text] [Related]
6. Clinical characteristics and outcomes for children, adolescents and young adults with "cic-fused" or "BCOR-rearranged" soft tissue sarcomas: A multi-institutional European retrospective analysis.
Sparber-Sauer M; Corradini N; Affinita MC; Milano GM; Pierron G; Carton M; Tirode F; Pissaloux D; Alaggio R; Vokuhl C; Bisogno G; Berlanga P; Ferrari A; Orbach D
Cancer Med; 2023 Jul; 12(13):14346-14359. PubMed ID: 37212486
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathological features of five cases of cic::DUX4 positive sarcomas, including literature review.
Rekhi B; Rumdee R; Shetty O
Ann Diagn Pathol; 2023 Aug; 65():152153. PubMed ID: 37167753
[TBL] [Abstract] [Full Text] [Related]
8. The effectiveness and mechanical properties of chemotherapy-impregnated cement in Ewing sarcoma.
Goldin AN; Healey RM
J Orthop Res; 2023 Nov; 41(11):2540-2546. PubMed ID: 36971130
[TBL] [Abstract] [Full Text] [Related]
9. Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors.
Isoyama S; Tamaki N; Noguchi Y; Okamura M; Yoshimatsu Y; Kondo T; Suzuki T; Yaguchi SI; Dan S
Cell Death Dis; 2023 Feb; 14(2):169. PubMed ID: 36849535
[TBL] [Abstract] [Full Text] [Related]
10. A global collaboRAtive study of cic-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl).
Palmerini E; Gambarotti M; Italiano A; Nathenson MJ; Ratan R; Dileo P; Provenzano S; Jones RL; DuBois SG; Martin-Broto J; de Alava E; Baldi GG; Grignani G; Ferraresi V; Brunello A; Paoluzzi L; Bertulli R; Hindi N; Montemurro M; Rothermundt C; Cocchi S; Salguero-Aranda C; Donati D; Martin JD; Abdelhamid Ahmed AH; Mazzocca A; Carretta E; Cesari M; Pierini M; Righi A; Sbaraglia M; Laginestra MA; Scotlandi K; Dei Tos AP; Ibrahim T; Stacchiotti S; Vincenzi B
Eur J Cancer; 2023 Apr; 183():11-23. PubMed ID: 36791667
[TBL] [Abstract] [Full Text] [Related]
11. Malignant Progression of an Ancestral Bone Marrow Clone Harboring a cic-NUTM2A Fusion in Isolated Myeloid Sarcoma.
Kamens JL; Dang J; Shaw TI; Gout AM; Newman S; Hagiwara K; Smith AMR; Obermayer AN; Aldridge S; Ma J; Zhang Y; Wu G; Leventaki V; Santiago T; Raimondi S; Nakitandwe J; Pappo A; Li C; Zhang J; Gruber TA
Mol Cancer Res; 2023 Apr; 21(4):301-306. PubMed ID: 36637394
[TBL] [Abstract] [Full Text] [Related]
12. Patterns of care and outcome of cic-rearranged sarcoma patients: A nationwide study of the French sarcoma group.
Brahmi M; Gaspar N; Gantzer J; Toulmonde M; Boudou-Rouquette P; Bompas E; Firmin N; Valentin T; Cancel M; Duffaud F; Bertucci F; Perrin C; Dufresne A; Marec-Bérard P; Jean-Denis M; Ray-Coquard I; Le Loarer F; Pierron G; Tirode F; Blay JY; Watson S
Cancer Med; 2023 Apr; 12(7):7801-7807. PubMed ID: 36537582
[TBL] [Abstract] [Full Text] [Related]
13. Small round cell sarcomas.
Cidre-Aranaz F; Watson S; Amatruda JF; Nakamura T; Delattre O; de Alava E; Dirksen U; Grünewald TGP
Nat Rev Dis Primers; 2022 Oct; 8(1):66. PubMed ID: 36202860
[TBL] [Abstract] [Full Text] [Related]
14. Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.
Liu APY; Dhanda SK; Lin T; Sioson E; Vasilyeva A; Gudenas B; Tatevossian RG; Jia S; Neale G; Bowers DC; Hassall T; Partap S; Crawford JR; Chintagumpala M; Bouffet E; McCowage G; Broniscer A; Qaddoumi I; Armstrong G; Wright KD; Upadhyaya SA; Vinitsky A; Tinkle CL; Lucas J; Chiang J; Indelicato DJ; Sanders R; Klimo P; Boop FA; Merchant TE; Ellison DW; Northcott PA; Orr BA; Zhou X; Onar-Thomas A; Gajjar A; Robinson GW
Acta Neuropathol; 2022 Oct; 144(4):733-746. PubMed ID: 35982322
[TBL] [Abstract] [Full Text] [Related]
15. A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.
Attia S; Bolejack V; Ganjoo KN; George S; Agulnik M; Rushing D; Loggers ET; Livingston MB; Wright J; Chawla SP; Okuno SH; Reinke DK; Riedel RF; Davis LE; Ryan CW; Maki RG
Cancer Med; 2023 Jan; 12(2):1532-1539. PubMed ID: 35950293
[TBL] [Abstract] [Full Text] [Related]
16. Plocabulin, a Novel Tubulin Inhibitor, Has Potent Antitumour Activity in Patient-Derived Xenograft Models of Soft Tissue Sarcoma.
Wang Y; Wozniak A; Cornillie J; Avilés P; Debiec-Rychter M; Sciot R; Schöffski P
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806460
[TBL] [Abstract] [Full Text] [Related]
17. cic-DUX4 sarcomas.
Brahmi M; Vanacker H; Macagno N; Tirode F; Dufresne A
Curr Opin Oncol; 2022 Jul; 34(4):342-347. PubMed ID: 35730520
[TBL] [Abstract] [Full Text] [Related]
18. Systemic treatments and outcomes in cic-rearranged Sarcoma: A national multi-centre clinicopathological series and literature review.
Connolly EA; Bhadri VA; Wake J; Ingley KM; Lewin J; Bae S; Wong DD; Long AP; Pryor D; Thompson SR; Strach MC; Grimison PS; Mahar A; Bonar F; Maclean F; Hong A
Cancer Med; 2022 Apr; 11(8):1805-1816. PubMed ID: 35178869
[TBL] [Abstract] [Full Text] [Related]
19. Distinct histologic and genetic characteristics of round cell sarcoma with cic-DUX4 fusion and comparison with ewing sarcoma.
Song MJ; Cho KJ; Kim TI; Kim W; Song JS
Pathol Res Pract; 2022 Mar; 231():153779. PubMed ID: 35151033
[TBL] [Abstract] [Full Text] [Related]
20. 3D-printing magnesium-polycaprolactone loaded with melatonin inhibits the development of osteosarcoma by regulating cell-in-cell structures.
Zhang W; Zhao W; Li Q; Zhao D; Qu J; Yuan Z; Cheng Z; Zhu X; Zhuang X; Zhang Z
J Nanobiotechnology; 2021 Sep; 19(1):263. PubMed ID: 34481503
[TBL] [Abstract] [Full Text] [Related]
[Next]
